NORTH AMERICA STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report has concluded the stem cell market in North America to expect growth at a CAGR of 7.41% during the forecast period 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market are:

•        United States

•        Canada

The rising R&D spending to develop innovative stem cell therapies to treat chronic and rare conditions is anticipated to motivate the stem cell market’s progress in the United States. Additionally, the country’s healthcare infrastructure is well-developed compared to most developed nations, with a high number of products in line for stem cell therapies. This further adds to the studied market’s progress. Moreover, the growing number of cancer cases opens new avenues for market players, leading to a rise in R&D activities among players to launch new stem cell therapies.

Furthermore, the pandemic outbreak has increased research activities to treat the spread of the virus. Here, stem cell therapy can be termed as a promising approach in COVID-19 treatment. However, its research is still in its initial stage. For instance, Lineage Cell Therapeutics obtained significant funding from the California Institute for Regenerative Medicine to support VAC’s use, allogeneic dendritic cell therapy to develop a potential vaccine to limit the spread of the virus. Such actions indicate a robust growth of the stem cell market in the upcoming years.

Likewise, Canada is among the leading countries in stem cell research, with researchers implementing stem cell therapy in the healthcare sector to treat several conditions. There is a high incidence rate of heart diseases in the country, which enhances the need for the development of innovative stem cell therapies for treating heart conditions. Additionally, the rising focus on stem cell research is also likely to motivate the growth of the stem cell market across Canada in the near future.

Cytori Therapeutics is a pharmaceutical company involved in the development of medical devices that permit the therapeutic usage of regenerative cells and adult stem found with the adipose (fat) tissue. It provides its products to physicians and patients at point-of-service. Moreover, the firm’s commercial activities are mainly concentrated on cell banking, cosmetic & reconstructive surgery, and distribution of research tools. It has its headquarter in Texas, the United States. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA STEM CELL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTE PRODUCTS

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY INSIGHTS

2.9. MARKET DRIVERS

2.9.1. GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.9.2. SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.9.3. RISING DEMAND FOR REGENERATIVE MEDICINE

2.10. MARKET RESTRAINTS

2.10.1. ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.10.2. HIGH COST OF STEM CELL PROCEDURES

2.10.3. STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.11. MARKET OPPORTUNITIES

2.11.1. ADVANCEMENT IN TECHNOLOGY

2.11.2. RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    NORTH AMERICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    NORTH AMERICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1. STEM CELL APHERESIS

4.2.2. STEM CELL BONE MARROW MARKET

4.2.3. STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1. STEM CELL CULTURE

4.4.2. THERAPEUTIC CLONING

4.4.3. IVF

5.    NORTH AMERICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    NORTH AMERICA STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1. HEMATOPOIETIC STEM CELL

6.1.2. NEURAL STEM CELL

6.1.3. UMBILICAL CORD STEM CELL

6.1.4. MESENCHYMAL STEM CELL

6.1.5. DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    NORTH AMERICA STEM CELL MARKET OUTLOOK - BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GEOGRAPHICAL ANALYSIS - NORTH AMERICA

8.1. COUNTRY ANALYSIS

8.1.1. UNITED STATES

8.1.2. CANADA

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12. MERCK KGAA (SIGMA ALDRICH)

9.13. THERMO FISHER SCIENTIFIC INC

9.14. ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1. OBJECTIVES OF STUDY

10.1.2. SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1. PRIMARY DATA SOURCES

10.2.2. SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1. EVALUATION OF PROPOSED MARKET

10.3.2. IDENTIFICATION OF DATA SOURCES

10.3.3. ASSESSMENT OF MARKET DETERMINANTS

10.3.4. DATA COLLECTION

10.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1        NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        NORTH AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        NORTH AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        NORTH AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9        NORTH AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      NORTH AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      NORTH AMERICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      NORTH AMERICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      NORTH AMERICA STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      NORTH AMERICA STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      NORTH AMERICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      NORTH AMERICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      NORTH AMERICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      NORTH AMERICA STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   NORTH AMERICA STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   NORTH AMERICA STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   NORTH AMERICA STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   NORTH AMERICA STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   NORTH AMERICA STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   NORTH AMERICA STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   NORTH AMERICA STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   NORTH AMERICA STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   NORTH AMERICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   NORTH AMERICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   NORTH AMERICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   NORTH AMERICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   NORTH AMERICA STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 25   NORTH AMERICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   NORTH AMERICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   NORTH AMERICA STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   NORTH AMERICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   NORTH AMERICA STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   NORTH AMERICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   NORTH AMERICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   NORTH AMERICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   UNITED STATES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   CANADA STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;